Those with obesity-related comorbidities such as obstructive sleep apnea, nonalcoholic fatty liver disease, osteoarthritis, or polycystic ovary syndrome may experience improvements in these conditions as a result of significant weight reduction, though these are not FDA-approved indications for semaglutide
There's no denying that weight loss drugs like Wegovy (semaglutide) have changed the game for a lot of people when it comes to losing weight
Patients with a history of diabetic retinopathy should be monitored for progression of diabetic retinopathy during treatment
This graduated approach gives your body time to adapt, reduces nausea and gastrointestinal side effects, and allows your provider to monitor how you respond before each increase
7 Beyond weight loss Semaglutide has gained significant attention for its positive effects in managing type 2 diabetes (T2D), obesity, and cardiovascular risk reduction